Categories: HealthcareNews

Lead Glass Pro Launches Turn-Key X-Ray Room Installation Service Across 26 States

Expansion strengthens production capacity, shortens lead times, and broadens custom radiation shielding solutions.

LAGUNA BEACH, Calif., June 11, 2026 /PRNewswire/ — Lead Glass Pro, a leading U.S. manufacturer of radiation shielding products, today announced a significant expansion of its manufacturing facilities alongside a major investment in advanced CNC manufacturing technology. The initiative is designed to deliver greater value to customers by accelerating lead times, expanding product offerings, and increasing precision capabilities for custom radiation shielding components.

The expansion includes the acquisition of new CNC milling centers dedicated to the production of custom-machined lead parts, enabling Lead Glass Pro to provide highly specialized solutions for medical, industrial, and research environments. In addition, the company is implementing a state-of-the-art CNC fiber laser cutting system, advanced CNC press brake equipment, and other modern manufacturing technologies to streamline production workflows and improve overall operational efficiency.

“Our customers rely on us for speed, compliance, and reliability,” said a Lead Glass Pro spokesperson. “This expansion represents a strategic investment in our ability to meet growing demand while maintaining the rapid turnaround times and precision standards that have become synonymous with our brand.”

By enhancing in-house machining and fabrication capabilities, Lead Glass Pro aims to reduce dependency on external suppliers and eliminate common bottlenecks that can delay critical shielding projects. The new equipment will support the production of a broader range of radiation shielding products, including custom lead components, fabricated shielding assemblies, and complex engineered solutions tailored to specific project requirements.

The expansion comes in response to increasing demand from healthcare providers, imaging centers, contractors, and facility planners seeking faster project execution without compromising quality or compliance. With more than 98% of orders historically shipping within three business days, Lead Glass Pro’s latest investment reinforces its commitment to setting new benchmarks for responsiveness and customer satisfaction within the radiation shielding industry.

“This is not just about scaling operations — it’s about delivering measurable value to our customers,” the spokesperson added. “From improved fabrication precision to expanded customization options, these upgrades ensure that our partners can complete their projects faster, with greater confidence and fewer complications.”

The facility expansion is expected to be fully operational in phases over the coming months, positioning Lead Glass Pro for continued growth and innovation. The company remains focused on advancing its mission to provide dependable, high-performance radiation shielding solutions that simplify installation, support regulatory compliance, and keep projects on schedule.

For more information about Lead Glass Pro and its expanded capabilities, visit leadglasspro.com.

Media Contact:
Lead Glass Pro
Email: sales@leadglasspro.com
Phone: (800) 506-9972

View original content to download multimedia:https://www.prnewswire.com/news-releases/lead-glass-pro-launches-turn-key-x-ray-room-installation-service-across-26-states-302798621.html

SOURCE Lead Glass Pro

Staff

Recent Posts

Fake Marijuana News: What the Cannabis Media Isn’t Telling Investors About the D.C. Circuit Rescheduling Challenge

See the complaint. When Commentary Becomes Advocacy? WASHINGTON, D.C. / ACCESS Newswire / June 13,…

3 hours ago

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease

Mitapivat demonstrated statistically significant improvement in hemoglobin response compared with placebo, with rapid onset and…

9 hours ago

New TALVEY®▼(talquetamab) plus daratumumab data demonstrate the potential strength of a novel bispecific combination in earlier-line relapsed or refractory multiple myeloma

TALVEY® plus daratumumab with or without pomalidomide showed progression-free survival of up to 81.3% and overall survival of…

9 hours ago

Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

DALLAS, June 12, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and…

9 hours ago